SG Capital offloads 731,892 Haemonetics shares (~$59.1M)

In a significant move, SG Capital Management has sold 731,892 shares of Haemonetics Corporation (NYSE: HAE), according to a Nov. 7 filing. The transaction reduces SG Capital’s stake to roughly 175,000 shares, valued at about $8.5 million as of Sept. 30. The sale brings Haemonetics down to approximately 0.8% of the fund’s assets under management (AUM), a sharp drop from 4.7% in the previous quarter. Despite recent earnings that showed a modest revenue decline and cautious full‑year guidance, SG Capital’s move suggests waning confidence in the company’s near‑term growth potential. #SGCapital #Haemonetics #hedgefundmoves #stocktransaction #SlimScan #GrowthStocks #CANSLIM